EMA To Up Transparency On Drug Safety By Publishing Risk Management Plans In Full
Executive Summary
Risk management plans are among the documents to which EU citizens, especially sponsors of generic medicines, most frequently request access. The European Medicines Agency has decided to publish these in full for new medicines rather than just publishing RMP summaries.